What five-sided inference does
Matched on what the molecule does
A kinase inhibitor and a PROTAC against the same target sit in different classification buckets and almost never surface in the same result set. We resolve on target, mechanism and structure, so both appear against the same gap.
Every inference shows its working
Each match states which axes it scored on and which came back neutral. Where structural similarity and target alignment are both neutral, the confidence is capped rather than dressed up. You see the reasoning before you act on the ranking.
The shortlist comes before the disclosure
Five to eight named counterparties, ranked by fit, inferred across pharma, platforms and capital at once. Broad outreach costs an asset its reputation, and every non-reply narrows what is left. The ranking happens first.
What we deliver
Six deliverables. Each one draws on more than one index at once.
Gap Closure Report
Every expiry gap gets one verdict: in-license, commission, or acquire. Where nothing suitable exists, we name who could build it.
Second trigger: the week a competitor licenses in your class. The same analysis runs on what is still available, and on who else is carrying the same gap.
The in-license verdict needs the asset index. The commission verdict needs the platform index. One index answers half the question.
Corporate development · Portfolio strategy
Inbound Triage
Send us the queue you cannot process. Every asset scored against your own gap map and ranked, with a stated reason for each position.
Ranking against revealed strategy needs the pharma index. Explaining each ranking, so a reviewer can act on it, needs the other four.
Pharma business development & licensing
China Deal-Readiness Radar
Which Chinese assets are actually workable this year. Every row states whether the rights position is documented or inferred.
Finding a Chinese asset needs one index. Saying whether it is workable, and what it would take, needs all five at once.
Pharma BD · Search & evaluation
Asset Placement Sprint
Five to eight named counterparties ranked by fit, with a route into each. Computed against revealed strategy rather than guessed from a press release.
A shortlist spanning pharma, platforms and capital is three indexes resolved into one ranking. A deal database gives you one of them.
Asset owners · License brokers · Biotech CEOs
Partnership Landscape
Who will partner with your portfolio company, and when. Board-ready, with the deal structures comparable transactions were done on.
Partners, de-riskers and co-funders sit in three different indexes. The report is the join between them, which cannot be bought off the shelf.
Investors
Patent Cliff License
Our patent cliff database as a structured file. 50+ companies and growing weekly, expiry by territory and franchise exposure. CSV and Parquet, nothing to log into.
Deliberately one side only. The value of the other four is in the join, and the join is not for sale.
Competitive intelligence · Advisory firms
See one before you commission one.
Request a sample report
Five indexes. One inference.
Everyone in this category holds one side well. Pipeline databases hold assets. Deal databases hold transactions. Cohort catalogs hold human evidence. Each is accurate, and each answers a question you did not ask.
A row from us states four things. The asset, named and staged. Why it fits, computed against your expiry exposure and what you already hold. What is missing, meaning the specific evidence gap and who could supply it. And who else carries the same gap, which is the line that tells you how long you have.
Four subscriptions and a week of an associate's time will produce three of those four, with no way to check that they agree. Five-sided by construction, not by claim. The vendors that hold one side well are holding one side.
Request a sample reportPowered by World-Class Infrastructure
Frequently Asked Questions
Our Team
Built by deal-makers and platform architects with deep pharma, data science and technology expertise, scaling partnerships to billion-dollar outcomes.
Achim Plueckebaum
Nora Volger
Lorenz Mayr
